NRC Health NRC
26.33 USD -0.23 (-0.87%)
Regular-session close
26.33 0.00 0.00%
After hours · Nov 16, 4:00 PM ET
25.99 Day range 26.67
11.74 52-week range 27.60
- YTD
- +40.28%
- 1 year
- +72.88%
News
etftrends.com NRC Issues Permit for Reactors Powering Chemical Plant The Nuclear Regulatory Commission (NRC) issued a construction permit last week for four reactors to be built at a chemical plant in Texas. The Xe-100 high-temperature gas-cooled reactors (HTGRs),…
globenewswire.com RecycLiCo receives funding from the National Research Council of Canada to collaborate on advancing AI-driven optimization of a hydrometallurgical platform for critical minerals recovery DELTA, British Columbia, Nov. 16, 2026 (GLOBE NEWSWIRE) -- RecycLiCo Battery Materials Inc. (RecycLiCo) (TSX.V: AMY | OTCQB: AMYZF | FSE: ID4), a critical minerals refining and lithium-ion battery…benzinga.com Citizens Maintains Market Outperform on NRC Health, Raises Price Target to $27 Citizens analyst Constantine Davides maintains NRC Health (NASDAQ:NRC) with a Market Outperform and raises the price target from $26 to $27.
benzinga.com National Research Q3 2026 Earnings Call Transcript National Research (NASDAQ:NRC) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…benzinga.com National Research Q3 Adj. EPS $0.21, Inline, Sales $38.399M Beat $35.800M Estimate National Research (NASDAQ:NRC) reported quarterly earnings of $0.21 per share which met the analyst consensus estimate. This is a 8.7 percent decrease over earnings of $0.23 per share from the same…
benzinga.com NRC Health Appoints CEO Trent Green As Interim Principal Financial Officer On October 14, 2026, the board of directors of NRC Health, a Delaware corporation (the "Company"), designated Trent Green, the Company’s Chief Executive Officer, to serve as the Company’s interim…
